With QPatch HTX Sophion further enables the use of giga-seal patch clamping for compound screening within ion channel drug discovery. QPatch HTX can be applied to all types of ion channels, including ligand-gated and voltage-gated channels. Data from the new system will be shown at Sophion’s QPatch User Meeting during the Biophysical Society’s conference, and more details will be provided at this time.
“An important part of Sophion’s business model has always been innovation through product development,” says Dr.
Sophion will have an exhibit at the Biophysical Society conference (Booth # 425). Conference attendees may visit the Sophion booth to hear more about QPatch HTX and to learn more about the QPatch and the QPatch Assay Software in general.
The QPatch HTX will be ready for shipment in Q4 2009. Upgrades of existing QPatch HT systems to QPatch HTX are available at the same time. For more information about the QPatch HTX please send an email to info@sophion.com or contact any of the representatives below.
About Sophion Bioscience
Sophion Bioscience, a leader in the automated patch clamp field, helps drug discovery companies make more and better drugs, faster. Sophion’s sole focus is to provide advanced products and integrated solutions for automated patch clamping. Sophion’s QPatch 16 and QPatch HT (48-channels) provide high-quality patch clamp data on a truly industrial basis on all types of ion channels. Only the QPatch has an integrated cell preparation and QPlate exchange facilities enabling several hours of unattended operation. The unique microfluidic flow channel system implemented in the QPlates enables fast liquid exchange around each cell and provides the option to test multiple compounds or increasing concentrations on the same cell. For more information about Sophion please visit www.sophion.com.
page top
Join our mailinglist